To analyze Surgical Site Infections in breast Cancer
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2024/06/068383
- Lead Sponsor
- Tata Memorial Centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All adult patients above 18 years posted for elective breast onco-surgery with curative intent, in TMH or ACTREC for a duration of six months, will be screened and included in the analysis
Exclusion Criteria
Emergency breast surgery
Pediatric patients below 18 years
Patients for palliative breast surgery
Patients with metastatic breast cancer
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link preoperative HbA1C levels to surgical site infections in breast cancer patients?
How does preoperative fasting blood glucose affect postoperative outcomes in breast oncological surgery?
Are there specific biomarkers that predict surgical site infection risk in breast cancer patients with diabetes?
What are the comparative effectiveness of infection prevention strategies in breast cancer surgeries at Tata Memorial Centre?
How do metabolic factors influence surgical site infection rates in C509 breast cancer patients undergoing oncological procedures?